UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 31

Sortiert nach

Assessing Women at High Risk of Breast Cancer: A Review of Risk Assessment Models

JNCI : Journal of the National Cancer Institute, 2010-05, Vol.102 (10), p.680-691

2010

Volltextzugriff (PDF)

Overcoming endocrine resistance in breast cancer—are signal transduction inhibitors the answer?

Breast cancer research and treatment, 2008-04, Vol.108 (3), p.307-317

2008

Volltextzugriff (PDF)

A phase 2 trial exploring the effects of high‐dose (10,000 IU/day) vitamin D3 in breast cancer patients with bone metastases

Cancer, 2010-01, Vol.116 (2), p.284-291

2010

Volltextzugriff (PDF)

Delayed hypersensitivity reactions to multiple aromatase inhibitors followed by successful desensitization to letrozole

Annals of allergy, asthma, & immunology, 2021-09, Vol.127 (3), p.378-379

2021

Volltextzugriff (PDF)

Abstract OT1-07-01: MRI screening versus symptom-directed surveillance for brain metastases among patients with triple negative or HER2+ metastatic breast cancer: A pilot study (nct03881605)

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.OT1-07-01-OT1-07-01

2022

Volltextzugriff (PDF)

Abstract OT1-01-01: A randomized, pragmatic trial investigating the timing of radiotherapy and endocrine in patients with early stage breast cancer (REaCT-RETT trial)

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.OT1-01-01-OT1-01-01

2022

Volltextzugriff (PDF)

Underestimation of risk by Gail model extends beyond women with atypical hyperplasia

Journal of clinical oncology, 2009-03, Vol.27 (9), p.1526; author reply 1527-1526

2009

Volltextzugriff (PDF)

Chemotherapy Dose-dense treatment for triple-negative breast cancer

Nature reviews. Clinical oncology, 2010-02, Vol.7 (2), p.79-80

2010

Volltextzugriff (PDF)

Abstract PD8-01: Phase 3 SOPHIA study of margetuximab (M) + chemotherapy (CTX) vs trastuzumab (T) + CTX in patients (pts) with HER2+ metastatic breast cancer (MBC) after prior anti-HER2 therapies: Final overall survival (OS) analysis

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.PD8-01-PD8-01

2022

Volltextzugriff (PDF)

A Randomized Trial Comparing Concurrent versus Sequential Radiation and Endocrine Therapy in Early-Stage, Hormone-Responsive Breast Cancer

Current oncology (Toronto), 2024-08, Vol.31 (8), p.4531-4545

2024

Volltextzugriff (PDF)

A phase 2 trial exploring the effects of high‐dose (10,000 IU/day) vitamin D 3 in breast cancer patients with bone metastases

Cancer, 2010-01, Vol.116 (2), p.284-291

2010

Volltextzugriff (PDF)

Biological insights into effective and antagonistic combinations of targeted agents with chemotherapy in solid tumors

Cancer and metastasis reviews, 2014-03, Vol.33 (1), p.295-307

2014

Volltextzugriff (PDF)

Filling in the gaps: reporting of concurrent supportive care therapies in breast cancer chemotherapy trials

Supportive care in cancer, 2011-03, Vol.19 (3), p.315-322

2011

Volltextzugriff (PDF)

Amenorrhoea, menopause, and endocrine therapy for breast cancer

BMJ. British medical journal (International ed.), 2010-01, Vol.340 (7736), p.48

International edition, 2010

Volltextzugriff (PDF)

Lapatinib plus paclitaxel as first-line therapy for patients with human epidermal growth factor receptor 2-positive metastatic breast cancer: inappropriate conclusions from a company-sponsored study?

Journal of clinical oncology, 2009-04, Vol.27 (11), p.1919; author reply 1920-1919

2009

Volltextzugriff (PDF)

Dose-dense treatment for triple-negative breast cancer

Nature reviews. Clinical oncology, 2010-02, Vol.7 (2), p.79-80

2010

Volltextzugriff (PDF)

Predicting benefit from fulvestrant in pretreated metastatic breast cancer patients

Breast cancer research and treatment, 2009-11, Vol.118 (1), p.377

2009

Volltextzugriff (PDF)

Amenorrhoea, menopause, and endocrine therapy for breast cancer

BMJ (British Medical Journal), 2009-12, Vol.339 (7736), p.b4261-50

2009

Volltextzugriff (PDF)

Treatment of locally advanced breast cancer

Canadian Medical Association journal (CMAJ), 2004-08, Vol.171 (3), p.219; author reply 221

2004

Volltextzugriff (PDF)

Delayed hypersensitivity reactions to multiple aromatase inhibitors followed by successful desensitization to letrozole

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2021, Vol.127 (3), p.378-379

2021

Volltextzugriff (PDF)

Treatment of locally advanced breast cancer

Canadian Medical Association journal (CMAJ), 2004-08, Vol.171 (3), p.219

2004

Volltextzugriff (PDF)

Characterization of the Lysogenic Repressor (c) Gene of the Pseudomonas aeruginosa Transposable Bacteriophage D3112

Virology (New York, N.Y.), 2000-06, Vol.272 (1), p.85-97

2000

Volltextzugriff (PDF)

Communication about palliative care and end-of-life planning

Supportive Oncology, 2011, p.513-520

2011

Volltextzugriff (PDF)

50 - Communication about palliative care and end-of-life planning

Supportive Oncology, 2011, p.513-520

2011

Volltextzugriff (PDF)

Hospital surveillance of respiratory viruses during the COVID-19 pandemic and beyond: contribution to the WHO mosaic framework, Israel, 2020 to 2023

Euro surveillance : bulletin européen sur les maladies transmissibles, 2024-08, Vol.29 (32)

2024

Volltextzugriff (PDF)

1 – 25 von 31

Suche als RSS-Feed

Aktive Filter

KollektionIngentaConnect Journals

ThemaAged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(28)
Mit Volltextzugriff
(23)

Publikationsform

Sprache

Englisch
(31)
Japanisch
(2)

Erscheinungsjahr

n.n

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Assessing Women at High Risk of Breast Cancer: A Review of Risk Assessment Models

Overcoming endocrine resistance in breast cancer—are signal transduction inhibitors the answer?

A phase 2 trial exploring the effects of high‐dose (10,000 IU/day) vitamin D3 in breast cancer patients with bone metastases

Delayed hypersensitivity reactions to multiple aromatase inhibitors followed by successful desensitization to letrozole

Abstract OT1-07-01: MRI screening versus symptom-directed surveillance for brain metastases among patients with triple negative or HER2+ metastatic breast cancer: A pilot study (nct03881605)

Abstract OT1-01-01: A randomized, pragmatic trial investigating the timing of radiotherapy and endocrine in patients with early stage breast cancer (REaCT-RETT trial)

Underestimation of risk by Gail model extends beyond women with atypical hyperplasia

Chemotherapy Dose-dense treatment for triple-negative breast cancer

Abstract PD8-01: Phase 3 SOPHIA study of margetuximab (M) + chemotherapy (CTX) vs trastuzumab (T) + CTX in patients (pts) with HER2+ metastatic breast cancer (MBC) after prior anti-HER2 therapies: Final overall survival (OS) analysis

A Randomized Trial Comparing Concurrent versus Sequential Radiation and Endocrine Therapy in Early-Stage, Hormone-Responsive Breast Cancer

A phase 2 trial exploring the effects of high‐dose (10,000 IU/day) vitamin D 3 in breast cancer patients with bone metastases

Biological insights into effective and antagonistic combinations of targeted agents with chemotherapy in solid tumors

Filling in the gaps: reporting of concurrent supportive care therapies in breast cancer chemotherapy trials

Amenorrhoea, menopause, and endocrine therapy for breast cancer

Lapatinib plus paclitaxel as first-line therapy for patients with human epidermal growth factor receptor 2-positive metastatic breast cancer: inappropriate conclusions from a company-sponsored study?

Dose-dense treatment for triple-negative breast cancer

Predicting benefit from fulvestrant in pretreated metastatic breast cancer patients

Amenorrhoea, menopause, and endocrine therapy for breast cancer

Treatment of locally advanced breast cancer

Delayed hypersensitivity reactions to multiple aromatase inhibitors followed by successful desensitization to letrozole

Treatment of locally advanced breast cancer

Characterization of the Lysogenic Repressor (c) Gene of the Pseudomonas aeruginosa Transposable Bacteriophage D3112

Communication about palliative care and end-of-life planning

50 - Communication about palliative care and end-of-life planning

Hospital surveillance of respiratory viruses during the COVID-19 pandemic and beyond: contribution to the WHO mosaic framework, Israel, 2020 to 2023

Aktive Filter

Suchergebnisse filtern